Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adam E Snook

Showing results (71-80 of 98) with videos related to

Pageof 10
Sort By:
Plos One|August 8, 2014
A novel CDX2 isoform regulates alternative splicingMatthew E Witek, Adam E Snook, Jieru E Lin, et al.
Oncoimmunology|November 18, 2016
GUCY2C-directed CAR-T cells oppose colorectal cancer metastases without autoimmunityMichael S Magee, Crystal L Kraft, Tara S Abraham, et al.
Toxins|November 10, 2011
Bacterial heat-stable enterotoxins: translation of pathogenic peptides into novel targeted diagnostics and therapeuticsJieru E Lin, Michael Valentino, Glen Marszalowicz, et al.
Expert Review of Clinical Pharmacology|August 27, 2013
Translating colorectal cancer prevention through the guanylyl cyclase C signaling axisErik S Blomain, Jieru E Lin, Crystal L Kraft, et al.
Journal of Medicinal Chemistry|March 21, 2020
pH-Dependent Grafting of Cancer Cells with Antigenic Epitopes Promotes Selective Antibody-Mediated CytotoxicityJanessa Wehr, Eden L Sikorski, Elizabeth Bloch, et al.
Human Pathology|February 5, 2019
Silencing the GUCA2A-GUCY2C tumor suppressor axis in CIN, serrated, and MSI colorectal neoplasiaBabar Bashir, Dante J Merlino, Jeffrey A Rappaport, et al.
Cancer Research|September 17, 2017
GUCY2C Signaling Opposes the Acute Radiation-Induced GI SyndromePeng Li, Evan Wuthrick, Jeff A Rappaport, et al.
The Journal of Clinical Investigation|August 26, 2011
A uroguanylin-GUCY2C endocrine axis regulates feeding in miceMichael A Valentino, Jieru E Lin, Adam E Snook, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 12, 2014
The paracrine hormone for the GUCY2C tumor suppressor, guanylin, is universally lost in colorectal cancerChantell Wilson, Jieru E Lin, Peng Li, et al.
Journal for Immunotherapy of Cancer|April 24, 2019
Split tolerance permits safe Ad5-GUCY2C-PADRE vaccine-induced T-cell responses in colon cancer patientsAdam E Snook, Trevor R Baybutt, Bo Xiang, et al.
Pageof 10

Showing results (71-80 of 98) with videos related to

Sort By:
Pageof 10
Plos One|August 8, 2014
A novel CDX2 isoform regulates alternative splicingMatthew E Witek, Adam E Snook, Jieru E Lin, et al.
Oncoimmunology|November 18, 2016
GUCY2C-directed CAR-T cells oppose colorectal cancer metastases without autoimmunityMichael S Magee, Crystal L Kraft, Tara S Abraham, et al.
Toxins|November 10, 2011
Bacterial heat-stable enterotoxins: translation of pathogenic peptides into novel targeted diagnostics and therapeuticsJieru E Lin, Michael Valentino, Glen Marszalowicz, et al.
Expert Review of Clinical Pharmacology|August 27, 2013
Translating colorectal cancer prevention through the guanylyl cyclase C signaling axisErik S Blomain, Jieru E Lin, Crystal L Kraft, et al.
Journal of Medicinal Chemistry|March 21, 2020
pH-Dependent Grafting of Cancer Cells with Antigenic Epitopes Promotes Selective Antibody-Mediated CytotoxicityJanessa Wehr, Eden L Sikorski, Elizabeth Bloch, et al.
Human Pathology|February 5, 2019
Silencing the GUCA2A-GUCY2C tumor suppressor axis in CIN, serrated, and MSI colorectal neoplasiaBabar Bashir, Dante J Merlino, Jeffrey A Rappaport, et al.
Cancer Research|September 17, 2017
GUCY2C Signaling Opposes the Acute Radiation-Induced GI SyndromePeng Li, Evan Wuthrick, Jeff A Rappaport, et al.
The Journal of Clinical Investigation|August 26, 2011
A uroguanylin-GUCY2C endocrine axis regulates feeding in miceMichael A Valentino, Jieru E Lin, Adam E Snook, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 12, 2014
The paracrine hormone for the GUCY2C tumor suppressor, guanylin, is universally lost in colorectal cancerChantell Wilson, Jieru E Lin, Peng Li, et al.
Journal for Immunotherapy of Cancer|April 24, 2019
Split tolerance permits safe Ad5-GUCY2C-PADRE vaccine-induced T-cell responses in colon cancer patientsAdam E Snook, Trevor R Baybutt, Bo Xiang, et al.
Pageof 10